Email This Release
Knopp Biosciences Announces Positive Top-Line Results from the Phase 2 EXHALE Trial of Oral Dexpramipexole in Moderate-to-Severe Eosinophilic Asthma
*
marks required fields
Recipient Name:
*
Recipient Email:
Message:
*
Enter security words: